Your browser doesn't support javascript.
loading
Tofacitinib Suppresses IL-10/IL-10R Signaling and Modulates Host Defense Responses in Human Macrophages.
Knoke, Kristin; Rongisch, Robert R; Grzes, Katarzyna M; Schwarz, Roman; Lorenz, Beate; Yogev, Nir; Pearce, Erika L; Pearce, Edward J; Kofler, David M; Fabri, Mario.
Afiliação
  • Knoke K; Department of Dermatology and Venereology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Rongisch RR; Department of Dermatology and Venereology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Grzes KM; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Schwarz R; MVZ Dr Stein and colleagues, Mönchengladbach, Germany.
  • Lorenz B; Department of Dermatology and Venereology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Yogev N; Department of Dermatology and Venereology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Pearce EL; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Pearce EJ; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA; Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hop
  • Kofler DM; Department I of Internal Medicine, University of Cologne, Cologne, Germany.
  • Fabri M; Department of Dermatology and Venereology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Electronic address: mario.fabri@uk-koeln.de.
J Invest Dermatol ; 142(3 Pt A): 559-570.e6, 2022 03.
Article em En | MEDLINE | ID: mdl-34536483

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor 4 Toll-Like / Inibidores de Janus Quinases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor 4 Toll-Like / Inibidores de Janus Quinases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha